(6S,7S)-3,10-Dimethoxy-6,7-dimethyl-5,6,7,8-tetrahydro-dibenzo[a,c]cyclooctene-1,2,6,11,12-pentaol

ID: ALA1089841

PubChem CID: 46884995

Max Phase: Preclinical

Molecular Formula: C20H24O7

Molecular Weight: 376.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(c(O)c1O)-c1c(cc(OC)c(O)c1O)C[C@](C)(O)[C@@H](C)C2

Standard InChI:  InChI=1S/C20H24O7/c1-9-5-10-6-12(26-3)16(21)18(23)14(10)15-11(8-20(9,2)25)7-13(27-4)17(22)19(15)24/h6-7,9,21-25H,5,8H2,1-4H3/t9-,20-/m0/s1

Standard InChI Key:  IYKSKVXKVLIBTQ-LXGOIASLSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -4.1853  -16.4893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1865  -17.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4708  -17.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7536  -17.3171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7565  -16.4857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4726  -16.0760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4692  -18.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1862  -18.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1867  -19.7920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4710  -20.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7533  -19.7887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7562  -18.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0898  -17.3319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0022  -18.9546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5309  -17.7366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5017  -18.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4751  -15.2501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7611  -14.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9007  -16.0765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9021  -17.7300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9009  -18.5529    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9023  -20.2045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4701  -21.0319    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7544  -21.4441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7884  -18.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9469  -17.1484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8176  -18.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4 13  1  0
  1  2  2  0
 12 14  1  0
  3  4  2  0
 13 15  1  0
  7  8  2  0
 14 16  1  0
 15 16  1  0
  6 17  1  0
  8  9  1  0
 17 18  1  0
  4  5  1  0
  1 19  1  0
  9 10  2  0
  2 20  1  0
  2  3  1  0
  8 21  1  0
 10 11  1  0
  9 22  1  0
  5  6  2  0
 10 23  1  0
 11 12  2  0
 23 24  1  0
 12  7  1  0
 16 25  1  1
  3  7  1  0
 15 26  1  0
  6  1  1  0
 15 27  1  1
M  END

Associated Targets(non-human)

PTGS2 Cyclooxygenase-2 (1953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 376.41Molecular Weight (Monoisotopic): 376.1522AlogP: 2.68#Rotatable Bonds: 2
Polar Surface Area: 119.61Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.15CX Basic pKa: CX LogP: 2.80CX LogD: 2.73
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: 1.64

References

1. Blunder M, Pferschy-Wenzig EM, Fabian WM, Hüfner A, Kunert O, Saf R, Schühly W, Bauer R..  (2010)  Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.,  18  (7): [PMID:20236826] [10.1016/j.bmc.2009.10.031]

Source